7,574.50

+197.64

+2.68%

52,512.07

+1,226.34

+2.39%

25,339.25

+759.82

+3.09%

2,850.61

+96.50

+3.50%

4.8640

+0.0050

+0.10%

19.71

-5.93

-23.12%

4,147.30

+72.40

+1.78%

74,720.47

-923.11

-1.22%

Crude Oil Dec 26

86.20

-4.63

-5.10%

US Private Equity

10,772.76

+11.86

+0.11%

NasdaqCM - Nasdaq Real Time Price USD

Starling Oncology, Inc. (STLNW)

0.0148 +0.0017 (+12.98%)

As of 12:18:43 PM EST. Market Open.

Loading Chart for STLNW

Chart Range Bar

Interval:

In partnership with ChartIQ

Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale

Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Oncology Institute Q3 Earnings Call Highlights

Oncology Institute Q3 Earnings Call Highlights

Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates

Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates

Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Geron (GERN) Reports Break-Even Earnings for Q3

Geron (GERN) Reports Break-Even Earnings for Q3

Ultragenyx (RARE) Reports Q3 Loss, Lags Revenue Estimates

Ultragenyx (RARE) Reports Q3 Loss, Lags Revenue Estimates

Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

Starling Oncology (STLN) Stock Gets Fair Value Boost On Capitated Revenue And Nexus Views

Starling Oncology (STLN) Stock Gets Fair Value Boost On Capitated Revenue And Nexus Views

Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation

Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation

Starling Oncology to Participate in Wells Fargo Healthcare Conference

Starling Oncology to Participate in Wells Fargo Healthcare Conference

Mobilize your Website

View Site in Mobile | Classic

Share by: